was upgraded at J.P. Morgan to overweight from neutral. $32 price target. Company has a strong pipeline and Cinryze can exceed expectations, J.P. Morgan said.
STOCK COMMENTS/EPS CHANGES
estimates, target were cut at Jefferies through 2014. Company is seeing weaker end-market demand, Jefferies said. Buy rating and new $92 price target.
price target and estimates were increased at UBS. Estimates were increased due to the upcoming SFE ramp and modest upside from debt paydown, said UBS. The new price target is $67.
price target and estimates were increased at UBS to reflect the company's debt refinancing, UBS said. Price target goes to $52.
Cliffs Natural numbers cut at Credit Suisse. Shares are now seen reaching $10. Estimates were also reduced, as pricing can continue to erode in the domestic iron ore business, Credit Suisse said. Underperform rating.
Dr Pepper Snapple Group
price target was raised at Citigroup to $53. After meeting with management, Citi said it has increased confidence in its earnings outlook, which justifies a higher premium to the market.
estimates and price target were raised at Credit Suisse. Shares are now seen reaching $982. Estimates were also increased, as optimization platforms should help monetize mobile and tablet traffic, Credit Suisse said. Outperform rating.
numbers were boosted at Canaccord Genuity. Shares are now seen reaching $56. Estimates also upped, as the company is cutting costs, Canaccord said. Buy rating.
price target and estimates were increased at UBS. Estimates were increased after company provided guidance for fiscal 2013, said UBS. Low-single digit comp increases and 20-60 basis points of adjusted EBIT margin expansion are expected in fiscal 2013, UBS added. Price target goes to $35.
price target was raised at Oppenheimer. Shares are now seen reaching $30. Company can perform better, after lapping difficult comps, Oppenheimer said. Outperform rating.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on